Pluristem Therapeutics, Inc. (PSTI) - NASDAQ
  • timtrading | Send Message 23 Jun

    bollinger bands crossover http://tinyurl.com/omgjnw9 $CELG,$SABR,$CVS,$LLY,$LBTYA,$ARIA,$INFN,$LSXMK,$PSTI,$MSGN
    Reply
      • wilkinson99 | Send Message 22 Jun

        Top % Gainers: $KBSF 121% (Halted) $SPU 58%, $NYMX 31%, $CETX 25%, $INVT 24%, $SGY 23%, $ASPN 21%, $DELT $REXX $NROM $PSTI $SCTY $EPRS $RXII
        Reply
          • wilkinson99 | Send Message 22 Jun

            Premarket Top % Gainers: $SPU 65% (only 10K volume) $SUNW 16%, $SCTY 12%, $PSTI 10%, $NVCN 9%, $ECTE 7%, $WGO $OCN $EBIO $PBMD $MPET $DELT
            Reply
              • wilkinson99 | Send Message 22 Jun

                Premarket Top % Gainers: $SCTY 16%, $NVCN 16%, $PSTI 10%, $BCEI 9%, $EBIO 7%, $WGO 6% $SGY $SBGL $ERX $VALE $DGAZ $IAG $MRO $NUGT $PSO $CHK
                Reply
                  • wilkinson99 | Send Message 13 Apr

                    Top % Gainers: $FELP 39%, $RPRX 26%, $UNXL 22%, $APPS 18%, $EMKR 16%, $FMCC 15%, $GPRO 14%, $FNMA 13% $SID $NMM $LSCC $ARGS $GGB $PSTI $YINN
                    Reply
                      • Ray Dirks | Send Message 1 Mar

                        Pluristem's Radiation Antidote Bests Blockbuster Drug Neupogen $PSTI, $AMGN http://seekingalpha.com/p/2vzoo
                        Reply
                          • Colin Macleod | Send Message 21 Feb

                            Video of Stocks to Watch on February 22nd http://bit.ly/1owssdf $GPRO $SPY $AERI $SHOP $SEMI $ATHM $NAT $FSAM $PSTI $OCUL
                            Reply
                              • wilkinson99 | Send Message 17 Feb

                                Premarket Top % Gainers: $ATOS 45%, $PPHM 25%, $FOSL 14%, $PCLN 10%, $TEX 8%, $KMI 7%, $JNUG 6%, $ATHM $SPLS $BITA $UWTI $PSTI $FCX $SDRL
                                Reply
                                  • Sharon di Stefano | Send Message 3 Feb

                                    Pluristem's Placental Cells Prove Superior In Pre-Eclampsia A Leading Cause Of Maternal And Fetal Death $PSTI http://seekingalpha.com/a/2apy0
                                    Reply
                                      • Ray Dirks | Send Message 20 Jan

                                        Pluristem To Commence Go-To-Market Pivotal Trial In 2016 For $12 Billion Critical Limb Ischemia... $PSTI http://seekingalpha.com/p/2tb7c
                                        Reply
                                          Company Description
                                          Pluristem Therapeutics, Inc. is a biotechnology company engages in the provision of cell therapy development. It focuses on cell therapies for the treatment of diseases such as muscle injury, acute radiation syndrome, pulmonary arterial hypertension and others. Its products include PLacental... More
                                          Sector: Healthcare
                                          Industry: Biotechnology
                                          Country: United States